Ignite Creation Date:
2025-12-24 @ 2:15 PM
Ignite Modification Date:
2026-02-25 @ 8:17 PM
Study NCT ID:
NCT00511095
Status:
COMPLETED
Last Update Posted:
2019-04-30
First Post:
2007-07-25
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Open-Label Study of the Safety and Immunogenicity of HEPLISAV™ Hepatitis B Virus Vaccine
Sponsor:
Dynavax Technologies Corporation
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-06
Start Date Type:
None
Primary Completion Date:
2007-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-03
Completion Date Type:
ACTUAL
First Submit Date:
2007-07-25
First Submit QC Date:
None
Study First Post Date:
2007-08-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-03-01
Results First Submit QC Date:
None
Results First Post Date:
2017-04-12
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2010-06-22
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2019-04-16
Last Update Post Date:
2019-04-30
Last Update Post Date Type:
ACTUAL